Literature DB >> 29413845

Cadherins in vascular smooth muscle cell (patho)biology: Quid nos scimus?

Agne Frismantiene1, Maria Philippova1, Paul Erne1, Therese J Resink2.   

Abstract

Vascular smooth muscle cells (SMCs) phenotypes span a reversible continuum from quiescent/contractile (differentiated) to proliferative/synthetic (dedifferentiated) enabling them to perform a diversity of functions that are context-dependent and important for vascular tone-diameter homeostasis, vasculogenesis, angiogenesis or vessel reparation after injury. Dysregulated phenotype modulation and failure to maintain/regain the mature differentiated and contractile phenotypic state is pivotal in the development of vascular diseases such as atherosclerosis and restenosis after angioplasty and coronary bypass grafting. Many functions of SMCs such as adhesion, migration, proliferation, contraction, differentiation and apoptosis are regulated by a broad spectrum of cell-cell and cell-matrix adhesion molecules. Cadherins represent a superfamily of cell surface homophilic adhesion molecules with fundamental roles in morphogenetic and differentiation processes during development and in the maintenance of tissue integrity and homeostasis in adults. The cadherins have major inputs on signalling pathways and cytoskeletal assemblies that participate in regulating processes such as cell polarity, migration, proliferation, survival, phenotype and differentiation. Abnormalities in these processes have long been recognized to underlie pathological SMC-driven reparation, but knowledge on the involvement of cadherins is remarkably limited. This article presents a comprehensive review of cadherin family members currently identified on vascular SMCs in relation to their functions, molecular mechanisms of action and relevance for vascular pathology.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cadherins; Expression; Function; Signalling; Vascular disease; Vascular smooth muscle cells

Mesh:

Substances:

Year:  2018        PMID: 29413845     DOI: 10.1016/j.cellsig.2018.01.023

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  5 in total

1.  Small molecule FAK activator promotes human intestinal epithelial monolayer wound closure and mouse ulcer healing.

Authors:  Qinggang Wang; Shyam K More; Emilie E Vomhof-DeKrey; Mikhail Y Golovko; Marc D Basson
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

2.  Loss of GATA4 C-Terminus by p.S335X Mutation Modulates Coronary Artery Vascular Smooth Muscle Cell Phenotype.

Authors:  Ting-Yan Yu; Xin-Xin Chen; Qing-Wen Liu; Fang-Fang Ma; Hong-Lang Huang; Lei Zhou; Wei Zhang
Journal:  Mediators Inflamm       Date:  2021-09-11       Impact factor: 4.711

Review 3.  Role of Chemerin/ChemR23 axis as an emerging therapeutic perspective on obesity-related vascular dysfunction.

Authors:  Yingying Xie; Ling Liu
Journal:  J Transl Med       Date:  2022-03-22       Impact factor: 5.531

4.  Downregulation of lncRNA ZFAS1 inhibits the hallmarks of thyroid carcinoma via the regulation of miR‑302‑3p on cyclin D1.

Authors:  Wenjing Chen; Lili Zhai; Huiming Liu; Yuting Li; Qi Zhang; Dandan Xu; Weiye Fan
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

5.  5-LO-derived LTB4 plays a key role in MCP-1 expression in HMGB1-exposed VSMCs via a BLTR1 signaling axis.

Authors:  Jong Min Choi; Seung Eun Baek; Ji On Kim; Eun Yeong Jeon; Eun Jeong Jang; Chi Dae Kim
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.